These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7268958)

  • 21. Nephrolithiasis.
    Williams HE
    N Engl J Med; 1974 Jan; 290(1):33-8. PubMed ID: 4808499
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis.
    Coe FL; Kavalach AG
    N Engl J Med; 1974 Dec; 291(25):1344-50. PubMed ID: 4610395
    [No Abstract]   [Full Text] [Related]  

  • 23. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of recurrent calcium stones: diet versus drugs.
    Jaeger P
    Miner Electrolyte Metab; 1994; 20(6):410-3. PubMed ID: 7783704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.
    Arowojolu O; Goldfarb DS
    J Nephrol; 2014 Dec; 27(6):601-5. PubMed ID: 24687403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Urinary excretion of uric acid in patients with calcium nephrolithiasis].
    Surian M; Colussi G; Corradi B; Brenna S; Masi F; Radaelli L; Guastoni C; Aroldi A; Graziani G; Minetti L
    Minerva Nefrol; 1981; 28(1):93-6. PubMed ID: 7290513
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnostic markers in calcium nephrolithiasis--current and traditional ideas with a new look].
    Hess B
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2460-70. PubMed ID: 8571096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperuricosuric calcium oxalate nephrolithiasis.
    Coe FL
    Kidney Int; 1978 May; 13(5):418-26. PubMed ID: 661071
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL; Nakagawa Y; Asplin J; Parks JH
    Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of proteolytic enzymes, electrolytes and other factors on the crystallization of calcium oxalate in the urine].
    Börner RH; Brundig P; Mäurer F; Berg W; Baumann W
    Z Urol Nephrol; 1983 May; 76(5):327-31. PubMed ID: 6224367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation of the urinary excretion of uric acid, calcium and phosphorus in recurrent calcic nephrolithiasis].
    Surian M; Antonacci A; Aroldi A; Civati G; Macchi E; Bonforte G; Colussi G; Graziani G
    Minerva Nefrol; 1979; 26(3):309-13. PubMed ID: 262270
    [No Abstract]   [Full Text] [Related]  

  • 33. [Metabolic aspects of renal calcium calculi].
    Fuss M
    Acta Urol Belg; 1994 Jun; 62(2):19-24. PubMed ID: 8036999
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of high-dose uric acid on cellular proteome, intracellular ATP, tissue repairing capability and calcium oxalate crystal-binding capability of renal tubular cells: Implications to hyperuricosuria-induced kidney stone disease.
    Sutthimethakorn S; Thongboonkerd V
    Chem Biol Interact; 2020 Nov; 331():109270. PubMed ID: 32991862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examination of the urinary potential of hyperuricosuric patients to retard calcium oxalate precipitation.
    Goldwasser B; Sarig S; Azoury R; Orda S; Boichis H; Wax Y; Many M
    Eur Urol; 1985; 11(1):40-3. PubMed ID: 3987747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal handling of uric acid in patients with recurrent calcium nephrolithiasis and hyperuricosuria.
    Mateos Antón F; Puig JG; Gaspar G; Muñoz Sanz A; Herrero E; Ramos T; Martínez ME; Gómez Mantilla JM
    Nephron; 1984; 37(2):123-7. PubMed ID: 6728086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperoxaluria, enzymuria and nephrolithiasis.
    Khan SR; Hackett RL
    Contrib Nephrol; 1993; 101():190-3. PubMed ID: 8467674
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of allopurinol action in calcium oxalate stone formers.
    Tomlinson B; Al-Khader A; Cohen SL; Kasidas GP; Krywawych S; Edgar L; Rose GA
    Proc Eur Dial Transplant Assoc; 1981; 18():556-60. PubMed ID: 6276882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.